Texas Administrative Code
Title 26 - HEALTH AND HUMAN SERVICES
Part 1 - HEALTH AND HUMAN SERVICES COMMISSION
Chapter 306 - BEHAVIORAL HEALTH DELIVERY SYSTEM
Subchapter G - USE AND MAINTENANCE OF THE HEALTH AND HUMAN SERVICES COMMISSION PSYCHIATRIC DRUG FORMULARY
Section 306.357 - Adding a Drug to the HHSC Psychiatric Drug Formulary
Universal Citation: 26 TX Admin Code ยง 306.357
Current through Reg. 49, No. 38; September 20, 2024
(a) Applying to have a drug added to the HHSC Psychiatric Drug Formulary.
(1) Any member of
the PEFC, any service system component practitioner, or any contract
practitioner may apply to have a drug added to the HHSC Psychiatric Drug
Formulary by completing the New Drug Application form found in the HHSC
Psychiatric Drug Formulary on the HHSC Psychiatric Formulary website.
(2) Include the following with the
New Drug Application form:
(A) published
articles in biomedical literature that substantiate the efficacy and safety of
the proposed drug;
(B) information
on the advantages of the proposed drug compared with similar formulary drugs;
(C) a list of formulary drugs that
the proposed drug would replace or supplement; and
(D) cost effectiveness data.
(b) Submitting the application.
(1) An HHSC facility
practitioner or HHSC facility contract practitioner shall submit the
application to the facility's pharmacy and therapeutics committee for approval.
If the committee approves the application, the committee forwards the
application to the PEFC.
(2) A
non-facility service system component practitioner or non-facility service
system component contract practitioner shall submit the application to the
component's clinical/medical director or designee who determines if the
application is appropriate and complete, and if so, shall forward the
application to the PEFC.
(3) A
member of the PEFC shall submit the application directly to the PEFC.
(c) Considering the application. The PEFC considers the drug application and shall:
(1) approve the proposed drug's inclusion
and, if appropriate, approve audit criteria and recommend dosage guidelines;
(2) approve the proposed drug on a
trial basis for a specified period of time;
(3) approve the proposed drug as a reserve
drug, with guidelines;
(4)
postpone the decision until a later meeting; or
(5) deny the proposed drug's inclusion.
Disclaimer: These regulations may not be the most recent version. Texas may have more current or accurate information. We make no warranties or guarantees about the accuracy, completeness, or adequacy of the information contained on this site or the information linked to on the state site. Please check official sources.
This site is protected by reCAPTCHA and the Google
Privacy Policy and
Terms of Service apply.
